Brean Murray Carret & Co. Starts Boston Scientific (BSX) at Hold; No Clear Path to Growth Reacceleration & Mgmt Transition Makes for Tough Outlook

Article Stock Quotes (1) Comments (0)

Brean Murray Carret & Co. initiates coverage on Boston Scientific (NYSE: BSX) with a Hold.

Brean analyst says, "...A recently announced (and much to market observers' surprise) CEO transition puts another, significant hurdle on the 'road back' for investors."

For more ratings news on Boston Scientific click here and for the rating history of Boston Scientific click here.

Shares of Boston Scientific closed at $6.74 yesterday, with a 52 week range of $5.04-$7.96.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Boston Scientific (BSX) Reports Positive Results from NG PROMUS, EVOLVE
• Needham & Company Lifts Numbers on Marvell (MRVL) on Solid Results
• Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

Create E-mail Alert Related Categories

New Coverage

Related Entities

Brean Murray Carret & Co.

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?